Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patients Steered to Fewer Pharmacies May Fill More Prescriptions

Lisa Rapaport  |  September 9, 2015

(Reuters Health)—When patients have drug benefits that encourage them to save money by using certain pharmacies, they may end up filling more prescriptions, a company-funded study suggests.

Narrow pharmacy networks that cover prescriptions only at certain retailers and drug benefits that offer consumers lower out-of-pocket fees at a subset of preferred pharmacies have become more common in recent years as a way to limit premium increases and curb drug spending.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The plans have raised concerns that restricting coverage to certain drugstores might make some people less likely to fill prescriptions, especially if the in-network retailers are too far away, said senior study author Dr. William Shrank, chief scientific officer at CVS Health.

But this didn’t happen in the study from the CVS, one of the largest operators of retail pharmacies and mail-order prescription plans in the U.S.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Our research found that patients did not stop taking their medications, and the narrow networks actually enhanced patients’ use of medications through improved adherence,” Shrank said by email.

“This research is important because there are few opportunities in health care where we can both improve quality of care and health outcomes while managing costs,” he added.

To explore the link between narrow networks and consumer behavior, Shrank and colleagues analyzed data from 2012 to 2013 for members of CVS prescription plans and compared prescriptions filled before and after narrow networks were implemented.

Researchers focused on daily medications to manage chronic health problems such as high cholesterol, hypertension, diabetes and depression. They tracked how many days of pills were included in each prescription and how often patients got refills, a measure known as a medication-possession ratio (MPR).

The analysis included records for about 68,000 people who switched to narrow networks during the study period and about 150,000 individuals who didn’t.

Although the MPR improved for patients in both types of drug plans over the study period, the gains were more pronounced for people in the narrow networks.

For statins to manage cholesterol, the people who switched to narrow networks got timely refills about 78% of the time before the change and about 80% of the time after the switch. Roughly 81% of people who didn’t switch to narrow networks during the study got timely refills, though there was a slight increase from 2012 to 2013.

Among people who switched to narrow networks, about 80% got timely refills of blood pressure pills in 2012 and about 81% did so in 2013. For those who didn’t transition to narrow networks, timely refills increased slightly but remained at about 83% of prescriptions.

Page: 1 2 | Single Page
Share: 

Filed under:Drug Updates Tagged with:adherenceHealth InsuranceMedicationpharmacyprescription

Related Articles

    CVS Health to Acquire Aetna for $69 billion

    December 4, 2017

    (Reuters)—U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc. for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. This year’s largest corporate acquisition will combine one of the nation’s largest pharmacy benefits managers (PBMs) and pharmacy operators with…

    Study Says 1 Biosimilar Switch Is OK; Jury Still Out on Multiple Switches

    August 17, 2018

    AMSTERDAM—As more biosimilar drugs for rheumatic diseases make their way to market, evidence is growing that switching from the originator drug to a biosimilar tends to be effective, while the questions of switching back and forth, and switching multiple times using several different biosimilars, remain to be answered, an expert on the topic said at…

    2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News

    January 1, 2015

    Plus, hydrocodone combination products and brodalumab

    U.S. Drug Benefit Managers Clamp Down on Specialty Pharmacies

    November 17, 2015

    NEW YORK/LOS ANGELES (Reuters)—In recent days, the largest U.S. managers of private prescription drug benefits have cut off at least eight pharmacies that work closely with drugmakers, intensifying scrutiny of a system that helps inflate drug prices, officials at the benefit managers told Reuters. The terminations come from payers who together manage drug benefits for…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences